Sensei Biotherapeutics, Inc. SNSE 深 滬
等待開盤 06-25 09:30:00 美东时间
13.85
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 13.85
- 總市值 1858.59万
- 52周最高 36.76
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 6.325
- 委 比 0.00%
- 總股本 134.19万
- 歷史最高 530.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 5.00
- 每 手 1
- 風險率 8.85%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 大摩再上调希捷科技和西部数据目标价；多家大行首予Lincoln买入评级
今日重点评级关注：HC Wainwright & Co.：维持Elicio Therapeutics"买入"评级，目标价从17美元升至23美元；Leerink Partners：维持SAB Biotherapeutics"跑赢大市"评级，目标价从7美元升至12美元
06-16 11:34
Sensei Biotherapeutics changes name to Faeth Therapeutics
sei Biotherapeutics (SNSE) has changed its corporate name to Faeth Therapeutics. The company’s common stock is expected to begin trading on the Nasdaq Capital Market under the new ticker symbol “FTH” ...
06-15 21:55
Faeth Therapeutics Rebrands, Relocates and Overhauls Leadership
Sensei Biotherapeutics ( ($SNSE) ) has issued an update. On June 10, 2026, Faet...
06-15 21:03
美股大行评级 | 甲骨文绩后分歧大！5家上调，2家下调；Navan、Hinge Health、凯西通用获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从6美元升至10美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从14美元升至14.5美元
06-12 11:32
BTIG Initiates Coverage On Sensei Biotherapeutics with Buy Rating, Announces Price Target of $55
BTIG analyst Jeet Mukherjee initiates coverage on Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating and announces Price Target of $55.
06-11 18:15
Sensei Biotherapeutics Overhauls Capital Structure at 2026 Meeting
The latest update is out from Sensei Biotherapeutics ( ($SNSE) ). On June 10, 2...
06-11 05:45
Sensei Biotherapeutics shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating.
Sensei Biotherapeutics shares are trading higher after Cantor Fitzgerald initia...
05-30 00:43
美股大行评级 | 瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
05-29 18:09
Sensei Biotherapeutics Updates 2026 Board Reconstitution Plans
Sensei Biotherapeutics ( ($SNSE) ) just unveiled an update. On May 22, 2026, Se...
05-23 05:10
Citigroup Initiates Coverage On Sensei Biotherapeutics with Buy Rating, Announces Price Target of $55
Citigroup analyst Samantha Semenkow initiates coverage on Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating and announces Price Target of $55.
05-22 23:11
